You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 4, April 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ETIOLOGY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Relationship of Milan Antigen to Abnormal Serum Lipoprotein

Patricia E. Taylor, PhD; June D. Almeida, DSc; Arie J. Zuckerman, MD; John M. Leach, MA

Am J Dis Child. 1972;123(4):329-331.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In 1970 Del Prete et al1 described the detection by immunodiffusion in gel of a new antigen in the sera of patients with epidemic hepatitis by using an antiserum obtained in Milan from a multiple-transfused patient with aplastic anemia. A high proportion of 127 sera obtained from three different epidemics of short-incubation hepatitis, which were consistently negative when tested against antiserum to Australia antigen, reacted with the Milan antibody. Of the sera collected during the first two weeks of illness 90% gave positive precipitin lines. The antigen, which was named epidemic hepatitis-associated antigen, was cleared from the serum with clinical improvement. It was not detected in 2,000 control serum samples collected from routinely vaccinated persons in Milan, nor in the serum of 50 patients with other viral diseases. The exact nature of the antigen has remained obscure since it was first described. We have attempted to establish some of . . . [Full Text PDF of this Article]


Author Affiliations

London

From Department of Microbiology, London School of Hygiene and Tropical Medicine (Drs. Taylor and Zuckerman); Department of Virology Royal Postgraduate Medical School (Dr. Almeida); London; and Pfizer Ltd, Sandwich, Kent, England (J.M. Leach).


Footnotes

Reprint requests to Department of Microbiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT (Dr. Zuckerman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.